Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 18, Issue 11, Pages 981-991
Publisher
Informa UK Limited
Online
2018-10-25
DOI
10.1080/14737159.2018.1539668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma
- (2018) Yulian Mytsyk et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- miRNAs as potential regulators of mTOR pathway in renal cell carcinoma
- (2018) Inês Nogueira et al. PHARMACOGENOMICS
- miR-10b is a prognostic marker in clear cell renal cell carcinoma
- (2017) Heba W Z Khella et al. JOURNAL OF CLINICAL PATHOLOGY
- miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma
- (2017) Ning Lou et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A new semisynthetic cardenolide analog 3β-[2-(1-amantadine)- 1-on-ethylamine]-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines
- (2017) Elke Nolte et al. Oncotarget
- Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype
- (2016) Emmanuel I. Papadopoulos et al. BIOLOGICAL CHEMISTRY
- MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR
- (2016) Cheng Xiang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition
- (2016) Tana Machackova et al. TUMOR BIOLOGY
- MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients
- (2016) Magdalena Lukamowicz-Rajska et al. Oncotarget
- miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2
- (2016) Yu Gao et al. Oncotarget
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
- (2016) Roy Nofech-Mozes et al. Cancer Medicine
- Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma
- (2015) Heba W.Z. Khella et al. AMERICAN JOURNAL OF PATHOLOGY
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma
- (2015) X. Wang et al. MOLECULAR CANCER RESEARCH
- miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
- (2015) Heba W Z Khella et al. MOLECULAR THERAPY
- miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma
- (2015) Qing-Zhi Long et al. TUMOR BIOLOGY
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer
- (2015) Yann Christinat et al. Oncotarget
- Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma
- (2015) Wataru Nakata et al. Oncotarget
- Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma
- (2015) Inik Chang et al. Oncotarget
- Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis
- (2015) Kun Tang et al. Scientific Reports
- A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
- (2015) Cheng Wang et al. Scientific Reports
- MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients
- (2015) Angelo Gámez-Pozo et al. NEOPLASIA
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
- (2014) Daniel Vergho et al. BMC CANCER
- Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection
- (2014) Qiang Fu et al. CANCER SCIENCE
- MicroRNA-21 (miR-21) Post-Transcriptionally Downregulates Tumor Suppressor PDCD4 and Promotes Cell Transformation, Proliferation, and Metastasis in Renal Cell Carcinoma
- (2014) Xiancheng Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression
- (2014) X. Chen et al. CLINICAL CANCER RESEARCH
- The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma
- (2014) Helena K.M. Fritz et al. EUROPEAN JOURNAL OF CANCER
- Intratumoral heterogeneity in kidney cancer
- (2014) Christopher J Ricketts et al. NATURE GENETICS
- Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma
- (2014) Celia Prior et al. PLoS One
- Prognostic Role of MicroRNA-221 in Various Human Malignant Neoplasms: A Meta-Analysis of 20 Related Studies
- (2014) Jie Yang et al. PLoS One
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3
- (2013) Jun Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA profiles classify papillary renal cell carcinoma subtypes
- (2013) S Wach et al. BRITISH JOURNAL OF CANCER
- miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
- (2013) R I McCormick et al. BRITISH JOURNAL OF CANCER
- MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
- (2013) R M Silva-Santos et al. BRITISH JOURNAL OF CANCER
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
- (2013) HIDETO IWAMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma
- (2013) Guihua Wang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway
- (2013) Francisca Dias et al. PHARMACOGENOMICS
- The Contributions of HIF-Target Genes to Tumor Growth in RCC
- (2013) Ting Zhang et al. PLoS One
- Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
- (2013) Ana L. Teixeira et al. TUMOR BIOLOGY
- Tumour angiogenesis regulation by the miR-200 family
- (2013) Chad V. Pecot et al. Nature Communications
- MicroRNA 15a, Inversely Correlated to PKCα, Is a Potential Marker to Differentiate between Benign and Malignant Renal Tumors in Biopsy and Urine Samples
- (2012) Melanie von Brandenstein et al. AMERICAN JOURNAL OF PATHOLOGY
- Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma
- (2012) Stefan Hauser et al. Cancer Epidemiology
- Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy
- (2012) Zofia Wotschofsky et al. CLINICA CHIMICA ACTA
- The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney
- (2012) Gerben Duns et al. GENES CHROMOSOMES & CANCER
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients
- (2012) Ondrej Slaby et al. GENES CHROMOSOMES & CANCER
- Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas
- (2012) Zofia Wotschofsky et al. International Journal of Biological Sciences
- MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma
- (2012) Shunsuke Shinmei et al. INTERNATIONAL JOURNAL OF UROLOGY
- The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
- (2012) Hala Faragalla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
- (2012) Martina Redova et al. Journal of Translational Medicine
- Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
- (2012) Mohd Saif Zaman et al. PLoS One
- microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion
- (2012) Nirmalya Dey et al. PLoS One
- Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
- (2012) Xiwei Wu et al. PLoS One
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma
- (2012) Martina Redova et al. TUMOR BIOLOGY
- MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma
- (2011) Soichiro Yamamura et al. CARCINOGENESIS
- Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature
- (2011) Youssef M. Youssef et al. EUROPEAN UROLOGY
- mTOR Inhibitors in Advanced Renal Cell Carcinoma
- (2011) Martin H. Voss et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells
- (2011) Chisato Nakada et al. JOURNAL OF PATHOLOGY
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
- (2011) Nicole M.A. White et al. JOURNAL OF UROLOGY
- MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
- (2011) Lena M. Wulfken et al. PLoS One
- Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses
- (2011) Heba W. Z. Khella et al. TUMOR BIOLOGY
- The VHL-dependent regulation of microRNAs in renal cancer
- (2010) Calida S Neal et al. BMC Medicine
- Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
- (2010) Huiqing Liu et al. BMC Systems Biology
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- Hereditary Renal Cancer Syndromes: An Update of a Systematic Review
- (2010) Jérôme Verine et al. EUROPEAN UROLOGY
- Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates
- (2010) Paul L. Crispen et al. EUROPEAN UROLOGY
- Renal Oxygenation Suppresses VHL Loss-Induced Senescence That Is Caused by Increased Sensitivity to Oxidative Stress
- (2010) S. M. Welford et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
- (2010) Elena Favaro et al. PLoS One
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Microarray analysis of microRNA expression in renal clear cell carcinoma
- (2009) Y. Huang et al. EJSO
- MicroRNA profiling of human kidney cancer subtypes
- (2009) Petillo INTERNATIONAL JOURNAL OF ONCOLOGY
- The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
- (2009) Tsz-fung F. Chow et al. JOURNAL OF UROLOGY
- Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
- (2009) David Juan et al. UROLOGY
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c
- (2008) C Nakada et al. JOURNAL OF PATHOLOGY
- Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma
- (2008) G. Joel DeCastro et al. UROLOGIC CLINICS OF NORTH AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started